• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于疫苗应用的微粒的设计与递送方面

Aspects of the design and delivery of microparticles for vaccine applications.

作者信息

Jenkins P G, Coombes A G, Yeh M K, Thomas N W, Davis S S

机构信息

Proteus Molecular Design Ltd., Cheshire.

出版信息

J Drug Target. 1995;3(1):79-81. doi: 10.3109/10611869509015939.

DOI:10.3109/10611869509015939
PMID:7655826
Abstract

Mortality and morbidity data continue to indicate there is a compelling need for the derivation of a new generation of vaccine delivery systems that can be usefully applied via injection and also mucosally. One technology that has potential for design as an effective vaccine delivery system is the formulation of biodegradable microparticles from the polymers and poly lactide co-glycolide (PLGA) in particular. The potential advantages of the delivery of vaccines within such microparticles is discussed. The potential for eliciting and optimising immunity after the mucosal delivery of biodegradable microparticles is also discussed.

摘要

死亡率和发病率数据持续表明,迫切需要研发新一代疫苗递送系统,该系统既能通过注射有效应用,也能通过黏膜途径应用。一种有潜力设计成有效疫苗递送系统的技术,特别是由聚合物尤其是聚乳酸-乙醇酸共聚物(PLGA)制备可生物降解的微粒制剂。本文讨论了在这类微粒中递送疫苗的潜在优势。还讨论了可生物降解微粒经黏膜递送后激发和优化免疫的潜力。

相似文献

1
Aspects of the design and delivery of microparticles for vaccine applications.用于疫苗应用的微粒的设计与递送方面
J Drug Target. 1995;3(1):79-81. doi: 10.3109/10611869509015939.
2
Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens.用于疫苗抗原注射递送的可生物降解聚(乳酸-乙醇酸)微颗粒。
Adv Drug Deliv Rev. 2005 Jan 10;57(3):391-410. doi: 10.1016/j.addr.2004.09.003.
3
Oral delivery of poly(lactide-co-glycolide) encapsulated vaccines.聚(丙交酯-乙交酯)包封疫苗的口服给药。
Behring Inst Mitt. 1997 Feb(98):220-8.
4
Using TEM to couple transient protein distribution and release for PLGA microparticles for potential use as vaccine delivery vehicles.利用透射电子显微镜(TEM)将聚乳酸-羟基乙酸共聚物(PLGA)微粒的瞬时蛋白质分布与释放相结合,以潜在用作疫苗递送载体。
J Control Release. 2006 Jun 12;113(1):15-22. doi: 10.1016/j.jconrel.2006.03.018. Epub 2006 Apr 7.
5
Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives.使用聚(D,L-丙交酯-共-乙交酯)及其衍生物递送大分子治疗药物的纳米/微技术
J Control Release. 2008 Feb 11;125(3):193-209. doi: 10.1016/j.jconrel.2007.09.013. Epub 2007 Oct 22.
6
Oral delivery of micro-encapsulated DNA vaccines.微囊化DNA疫苗的口服递送。
Dev Biol Stand. 1998;92:149-55.
7
Cationic microparticles consisting of poly(lactide-co-glycolide) and polyethylenimine as carriers systems for parental DNA vaccination.由聚(丙交酯-共-乙交酯)和聚乙烯亚胺组成的阳离子微粒作为亲代DNA疫苗接种的载体系统。
J Control Release. 2005 May 18;104(2):359-77. doi: 10.1016/j.jconrel.2005.02.004. Epub 2005 Apr 15.
8
Biodegradable polymer microspheres as vaccine adjuvants and delivery systems.可生物降解的聚合物微球作为疫苗佐剂和递送系统。
Dev Biol Stand. 1998;92:63-78.
9
The long-term potential of biodegradable poly(lactide-co-glycolide) microparticles as the next-generation vaccine adjuvant.可生物降解的聚(乳酸-共-乙醇酸)微球作为下一代疫苗佐剂的长期潜力。
Expert Rev Vaccines. 2011 Dec;10(12):1731-42. doi: 10.1586/erv.11.126.
10
Biodegradable polymeric microspheres and nanospheres for drug delivery in the peritoneum.用于腹膜给药的可生物降解聚合物微球和纳米球。
J Biomed Mater Res A. 2006 May;77(2):351-61. doi: 10.1002/jbm.a.30654.

引用本文的文献

1
Effect of Experimental Parameters on Alginate/Chitosan Microparticles for BCG Encapsulation.实验参数对用于卡介苗包封的海藻酸盐/壳聚糖微粒的影响。
Mar Drugs. 2016 May 11;14(5):90. doi: 10.3390/md14050090.
2
Nasal delivery of PLG microparticle encapsulated defensin peptides adjuvanted gp41 antigen confers strong and long-lasting immunoprotective response against HIV-1.经鼻腔递送包裹防御素肽的聚乳酸-羟基乙酸共聚物(PLG)微粒佐剂化的gp41抗原,可对HIV-1产生强烈且持久的免疫保护反应。
Immunol Res. 2014 Jan;58(1):139-53. doi: 10.1007/s12026-013-8428-5.
3
Clinical immunology.
临床免疫学
BMJ. 1996 Jun 8;312(7044):1465-9. doi: 10.1136/bmj.312.7044.1465.